MEDICINOVA INC financial data

Symbol
MNOV on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1147% % -32%
Debt-to-equity 7.2% % 29%
Return On Equity -26% % -34%
Return On Assets -25% % -32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,221,246 shares 0.36%
Common Stock, Shares, Outstanding 49,221,246 shares 0.36%
Entity Public Float $62,397,025 USD -9%
Common Stock, Value, Issued $49,221 USD 0.36%
Weighted Average Number of Shares Outstanding, Basic 49,063,438 shares 0.04%
Weighted Average Number of Shares Outstanding, Diluted 49,063,438 shares 0.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $123,319 USD
Research and Development Expense $6,700,000 USD -1.5%
General and Administrative Expense $6,159,205 USD 12%
Operating Income (Loss) $13,283,002 USD -4.8%
Net Income (Loss) Attributable to Parent $11,997,957 USD -8.6%
Earnings Per Share, Basic -0.24 USD/shares -4.3%
Earnings Per Share, Diluted -0.24 USD/shares -4.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,806,477 USD -24%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD
Assets, Current $30,991,304 USD -25%
Property, Plant and Equipment, Net $8,340 USD -67%
Operating Lease, Right-of-Use Asset $184,229 USD -48%
Goodwill $9,600,240 USD 0%
Other Assets, Noncurrent $18,996 USD 0%
Assets $45,603,109 USD -18%
Accounts Payable, Current $624,995 USD -43%
Employee-related Liabilities, Current $824,529 USD 4.9%
Contract with Customer, Liability, Current $370,160 USD
Liabilities, Current $3,797,507 USD 28%
Deferred Income Tax Liabilities, Net $201,792 USD 0%
Operating Lease, Liability, Noncurrent $17,129 USD -92%
Other Liabilities, Noncurrent $17,129 USD -92%
Liabilities $4,016,428 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $127,180 USD 5.9%
Retained Earnings (Accumulated Deficit) $438,749,199 USD -2.8%
Stockholders' Equity Attributable to Parent $41,586,681 USD -21%
Liabilities and Equity $45,603,109 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,783,661 USD 2.2%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 49,221,246 shares 0.36%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,788,272 USD 1.9%
Deferred Tax Assets, Valuation Allowance $81,022,903 USD -4%
Deferred Tax Assets, Gross $82,215,878 USD -4%
Operating Lease, Liability $211,460 USD -48%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $11,989,983 USD -8.3%
Lessee, Operating Lease, Liability, to be Paid $223,752 USD -50%
Property, Plant and Equipment, Gross $431,149 USD 0.68%
Operating Lease, Liability, Current $194,331 USD 0.29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $17,269 USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One $206,483 USD -7.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12,292 USD -71%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $67,509,750 USD -5.1%
Unrecognized Tax Benefits $2,593,974 USD -3.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD
Operating Lease, Payments $223,999 USD -14%
Depreciation, Depletion and Amortization $5,177 USD -3.2%
Share-based Payment Arrangement, Expense $829,095 USD -30%